Literature DB >> 6210542

Reversal of left ventricular hypertrophy by antihypertensive therapy.

N Reichek, B B Franklin, T Chandler, A Muhammad, T Plappert, M St John Sutton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6210542     DOI： 10.1093/eurheartj/3.suppl_a.165

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine.

Authors:  I Sheiban; G Covi; C Zenorini; G Arcaro; E Arosio; S Tonni; G Montresor; A Lechi
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Electrophysiological impact of diuretics in heart failure.

Authors:  L Storstein
Journal:  Br Heart J       Date:  1994-08

3.  Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine.

Authors:  L A Ferrara; G de Simone; M Mancini; M L Fasano; F Pasanisi; G Vallone
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Current drug treatment and treatment patterns with antihypertensive drugs.

Authors:  E D Freis; V Papademetriou
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 5.  Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension.

Authors:  F H Messerli; R Schmieder
Journal:  Drugs       Date:  1986       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.